BG104394A - Indole derivative applicable as endotheliium receptor antagonist - Google Patents

Indole derivative applicable as endotheliium receptor antagonist

Info

Publication number
BG104394A
BG104394A BG104394A BG10439400A BG104394A BG 104394 A BG104394 A BG 104394A BG 104394 A BG104394 A BG 104394A BG 10439400 A BG10439400 A BG 10439400A BG 104394 A BG104394 A BG 104394A
Authority
BG
Bulgaria
Prior art keywords
endotheliium
receptor antagonist
indole derivative
derivative applicable
applicable
Prior art date
Application number
BG104394A
Other languages
Bulgarian (bg)
English (en)
Inventor
Stephen Challenger
Kevin DACK
Andrew Derrick
Roger DICKINSON
David Ellis
Yousef Hajikarimian
Kim James
David RAWSON
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of BG104394A publication Critical patent/BG104394A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG104394A 1997-10-22 2000-04-28 Indole derivative applicable as endotheliium receptor antagonist BG104394A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722287.1A GB9722287D0 (en) 1997-10-22 1997-10-22 Compounds useful in therapy

Publications (1)

Publication Number Publication Date
BG104394A true BG104394A (en) 2001-09-28

Family

ID=10820904

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104394A BG104394A (en) 1997-10-22 2000-04-28 Indole derivative applicable as endotheliium receptor antagonist

Country Status (17)

Country Link
US (1) US6211223B1 (fr)
AP (1) AP899A (fr)
AR (1) AR014922A1 (fr)
AU (1) AU1150999A (fr)
BG (1) BG104394A (fr)
CA (1) CA2308478C (fr)
CZ (1) CZ20001514A3 (fr)
DZ (1) DZ2628A1 (fr)
GB (1) GB9722287D0 (fr)
GT (1) GT199800161A (fr)
MA (1) MA26556A1 (fr)
MY (1) MY117148A (fr)
PA (1) PA8461001A1 (fr)
TN (1) TNSN98190A1 (fr)
TW (1) TW483893B (fr)
WO (1) WO1999020623A1 (fr)
ZA (1) ZA989574B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722287D0 (en) 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
CN106631920B (zh) * 2016-11-17 2018-11-13 贵州大学 一种2-羟基-4-甲基苯磺酸的制备方法
CN114507162A (zh) * 2020-11-16 2022-05-17 尚科生物医药（上海）有限公司 一种制备2-氟-5-甲氧基苯磺酰氯的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0617001B1 (fr) * 1993-03-19 2000-01-26 Merck & Co. Inc. Dérivés d'acide phénoxyphénylacétique
GB9609641D0 (en) * 1996-05-09 1996-07-10 Pfizer Ltd Compounds useful in therapy
GB9722287D0 (en) 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy

Also Published As

Publication number Publication date
PA8461001A1 (es) 2000-05-24
ZA989574B (en) 2000-04-25
AR014922A1 (es) 2001-04-11
CA2308478A1 (fr) 1999-04-29
TNSN98190A1 (fr) 2005-03-15
AP9801370A0 (en) 1998-12-31
CA2308478C (fr) 2004-12-07
TW483893B (en) 2002-04-21
US6211223B1 (en) 2001-04-03
CZ20001514A3 (cs) 2001-09-12
WO1999020623A1 (fr) 1999-04-29
AP899A (en) 2000-11-17
MA26556A1 (fr) 2004-12-20
DZ2628A1 (fr) 2003-03-08
GB9722287D0 (en) 1997-12-17
AU1150999A (en) 1999-05-10
GT199800161A (es) 2000-04-11
MY117148A (en) 2004-05-31

Similar Documents

Publication Publication Date Title
CZ305838B6 (cs) N-(2-arylethyl)benzylaminy jako antagonisté receptoru 5-HT6
TR200102490T2 (tr) Fenil ve piridinil türevleri
IS6275A (is) Heteróhringa efnasambönd og notkun þeirra sem mótlyf efnaskiptaglútamatviðtaka
HK1009046A1 (en) Morpholine tachykinin receptor antagonists
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
HRP20000292B1 (en) 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
BG103964A (en) SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS
JO2371B1 (en) 4-phenyl-pyridine derivatives
YU52000A (sh) Jedinjenja meta-azaciklične amino benzojeve kiseline i njihovi derivati, koji su antagonisti integrina
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
EP1019045A4 (fr) Agents antithrombotiques
EP0999834A4 (fr) Agents antithrombotiques
PL338352A1 (en) Derivatives of 1-(n-phenylaminoalkyl)-piperazine substituted at position 2 of its phenyl ring
YU9802A (sh) Inhibitori ćelijske adhezije
WO2003084936A8 (fr) Nouveaux derives de pyrimidinone amino-substitues
CA2191871A1 (fr) Derives de piperazine utilises comme antagonistes de 5ht1a
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
CA2244777A1 (fr) Derives de 2,3-benzodiazepine et leur utilisation comme inhibiteurs de recepteurs d'ampa
GB9718903D0 (en) Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
TR200000786T2 (tr) Vitronektin reseptör antagonisti
IL136100A (en) Biphenylamidine derivatives and pharmaceutical compositions containing the same
MX9707683A (es) Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan.
CA2356985A1 (fr) Antagonistes du recepteur 5ht1 pour therapie antidepressive
BG104394A (en) Indole derivative applicable as endotheliium receptor antagonist
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives